25 XP   0   0   10

Chong Kun Dang Pharmaceutical
Buy, Hold or Sell?

Let's analyse Chong Kun Dang Pharmaceutical together

PenkeI guess you are interested in Chong Kun Dang Pharmaceutical. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Chong Kun Dang Pharmaceutical. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Chong Kun Dang Pharmaceutical

I send you an email if I find something interesting about Chong Kun Dang Pharmaceutical.

Quick analysis of Chong Kun Dang Pharmaceutical (30 sec.)










What can you expect buying and holding a share of Chong Kun Dang Pharmaceutical? (30 sec.)

How much money do you get?

How much money do you get?
₩0.00
When do you have the money?
1 year
How often do you get paid?
68.0%

What is your share worth?

Current worth
₩64,096.56
Expected worth in 1 year
₩79,369.24
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
₩15,272.68
Return On Investment
15.4%

For what price can you sell your share?

Current Price per Share
₩99,200.00
Expected price per share
₩85,619 - ₩119,100
How sure are you?
50%

1. Valuation of Chong Kun Dang Pharmaceutical (5 min.)




Live pricePrice per Share (EOD)

₩99,200.00

Intrinsic Value Per Share

₩435,451.26 - ₩522,091.32

Total Value Per Share

₩499,547.83 - ₩586,187.89

2. Growth of Chong Kun Dang Pharmaceutical (5 min.)




Is Chong Kun Dang Pharmaceutical growing?

Current yearPrevious yearGrowGrow %
How rich?$570.9m$416.7m$86m17.1%

How much money is Chong Kun Dang Pharmaceutical making?

Current yearPrevious yearGrowGrow %
Making money$37.1m$14.1m$23m61.9%
Net Profit Margin12.4%5.5%--

How much money comes from the company's main activities?

3. Financial Health of Chong Kun Dang Pharmaceutical (5 min.)




What can you expect buying and holding a share of Chong Kun Dang Pharmaceutical? (5 min.)

Welcome investor! Chong Kun Dang Pharmaceutical's management wants to use your money to grow the business. In return you get a share of Chong Kun Dang Pharmaceutical.

What can you expect buying and holding a share of Chong Kun Dang Pharmaceutical?

First you should know what it really means to hold a share of Chong Kun Dang Pharmaceutical. And how you can make/lose money.

Speculation

The Price per Share of Chong Kun Dang Pharmaceutical is ₩99,200. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Chong Kun Dang Pharmaceutical.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Chong Kun Dang Pharmaceutical, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ₩64,096.56. Based on the TTM, the Book Value Change Per Share is ₩3,818.17 per quarter. Based on the YOY, the Book Value Change Per Share is ₩1,089.96 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ₩0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Chong Kun Dang Pharmaceutical.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps4.850.0%2.920.0%1.110.0%1.320.0%1.180.0%
Usd Book Value Change Per Share4.650.0%2.670.0%0.760.0%1.060.0%1.790.0%
Usd Dividend Per Share0.000.0%0.000.0%0.310.0%0.340.0%0.370.0%
Usd Total Gains Per Share4.650.0%2.670.0%1.070.0%1.400.0%2.160.0%
Usd Price Per Share91.63-67.27-60.65-76.93-77.18-
Price to Earnings Ratio4.72-6.07-15.21-36.72-39.43-
Price-to-Total Gains Ratio19.71-30.57-73.18-80.37-78.31-
Price to Book Ratio2.04-1.69-1.86-2.51-2.57-
Price-to-Total Gains Ratio19.71-30.57-73.18-80.37-78.31-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share69.44
Number of shares14
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.34
Usd Book Value Change Per Share2.671.06
Usd Total Gains Per Share2.671.40
Gains per Quarter (14 shares)37.4219.61
Gains per Year (14 shares)149.6778.42
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10150140195968
2029929038119146
3044944057178224
4059959077237302
5074874096296380
60898890115356458
7010481040134415536
8011971190153474614
9013471340172533692
10014971490192593770

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%25.00.00.0100.0%25.00.00.0100.0%
Book Value Change Per Share4.00.00.0100.0%9.03.00.075.0%17.03.00.085.0%21.03.01.084.0%21.03.01.084.0%
Dividend per Share0.00.04.00.0%6.00.06.050.0%12.00.08.060.0%17.00.08.068.0%17.00.08.068.0%
Total Gains per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%25.00.00.0100.0%25.00.00.0100.0%

Fundamentals of Chong Kun Dang Pharmaceutical

About Chong Kun Dang Pharmaceutical

Chong Kun Dang Pharmaceutical Corp. engages in the manufacturing, marketing, and sales of medicines in South Korea and internationally. It provides prescription drugs for anticancer, anti-hypertension, anti-hyperlipidemia, anti-diabetic, and immunosuppressant products; over-the-counter drugs for therapeutic benefits, supplements, and other preventive products; health supplements with preventive benefits including prebiotics and vitamins with Omega-3; and consumer health products, such as red-ginseng healthy drink, hand sanitizer, hair color, wound care medication, as well as insecticides. The company also exports its products. Chong Kun Dang Pharmaceutical Corp. was founded in 1941 and is headquartered in Seoul, South Korea.

Fundamental data was last updated by Penke on 2024-04-16 02:28:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is cheap.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of Chong Kun Dang Pharmaceutical.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Chong Kun Dang Pharmaceutical earns for each ₩1 of revenue.

  • Above 10% is considered healthy but always compare Chong Kun Dang Pharmaceutical to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 17.5% means that ₩0.17 for each ₩1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Chong Kun Dang Pharmaceutical:

  • The MRQ is 17.5%. The company is making a huge profit. +2
  • The TTM is 12.4%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ17.5%TTM12.4%+5.1%
TTM12.4%YOY5.5%+6.9%
TTM12.4%5Y6.6%+5.7%
5Y6.6%10Y6.2%+0.4%
1.1.2. Return on Assets

Shows how efficient Chong Kun Dang Pharmaceutical is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Chong Kun Dang Pharmaceutical to the Drug Manufacturers - Specialty & Generic industry mean.
  • 6.3% Return on Assets means that Chong Kun Dang Pharmaceutical generated ₩0.06 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Chong Kun Dang Pharmaceutical:

  • The MRQ is 6.3%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 4.1%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ6.3%TTM4.1%+2.2%
TTM4.1%YOY1.8%+2.3%
TTM4.1%5Y2.3%+1.9%
5Y2.3%10Y2.1%+0.2%
1.1.3. Return on Equity

Shows how efficient Chong Kun Dang Pharmaceutical is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Chong Kun Dang Pharmaceutical to the Drug Manufacturers - Specialty & Generic industry mean.
  • 10.8% Return on Equity means Chong Kun Dang Pharmaceutical generated ₩0.11 for each ₩1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Chong Kun Dang Pharmaceutical:

  • The MRQ is 10.8%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 7.2%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ10.8%TTM7.2%+3.6%
TTM7.2%YOY3.4%+3.8%
TTM7.2%5Y4.0%+3.2%
5Y4.0%10Y3.7%+0.3%

1.2. Operating Efficiency of Chong Kun Dang Pharmaceutical.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Chong Kun Dang Pharmaceutical is operating .

  • Measures how much profit Chong Kun Dang Pharmaceutical makes for each ₩1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Chong Kun Dang Pharmaceutical to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ₩0.00  for each ₩1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Chong Kun Dang Pharmaceutical:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY7.4%-7.4%
TTM-5Y6.7%-6.7%
5Y6.7%10Y7.0%-0.3%
1.2.2. Operating Ratio

Measures how efficient Chong Kun Dang Pharmaceutical is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.31 means that the operating costs are ₩1.31 for each ₩1 in net sales.

Let's take a look of the Operating Ratio trends of Chong Kun Dang Pharmaceutical:

  • The MRQ is 1.312. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.467. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.312TTM1.467-0.154
TTM1.467YOY1.422+0.045
TTM1.4675Y1.493-0.026
5Y1.49310Y1.498-0.005

1.3. Liquidity of Chong Kun Dang Pharmaceutical.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Chong Kun Dang Pharmaceutical is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.85 means the company has ₩1.85 in assets for each ₩1 in short-term debts.

Let's take a look of the Current Ratio trends of Chong Kun Dang Pharmaceutical:

  • The MRQ is 1.851. The company is able to pay all its short-term debts. +1
  • The TTM is 1.868. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.851TTM1.868-0.018
TTM1.868YOY1.929-0.060
TTM1.8685Y1.872-0.004
5Y1.87210Y1.772+0.100
1.3.2. Quick Ratio

Measures if Chong Kun Dang Pharmaceutical is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Chong Kun Dang Pharmaceutical to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.81 means the company can pay off ₩0.81 for each ₩1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Chong Kun Dang Pharmaceutical:

  • The MRQ is 0.811. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.691. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.811TTM0.691+0.121
TTM0.691YOY0.829-0.139
TTM0.6915Y0.759-0.069
5Y0.75910Y0.758+0.001

1.4. Solvency of Chong Kun Dang Pharmaceutical.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Chong Kun Dang Pharmaceutical assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Chong Kun Dang Pharmaceutical to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.42 means that Chong Kun Dang Pharmaceutical assets are financed with 41.8% credit (debt) and the remaining percentage (100% - 41.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Chong Kun Dang Pharmaceutical:

  • The MRQ is 0.418. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.429. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.418TTM0.429-0.011
TTM0.429YOY0.459-0.030
TTM0.4295Y0.431-0.002
5Y0.43110Y0.410+0.022
1.4.2. Debt to Equity Ratio

Measures if Chong Kun Dang Pharmaceutical is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Chong Kun Dang Pharmaceutical to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 71.9% means that company has ₩0.72 debt for each ₩1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Chong Kun Dang Pharmaceutical:

  • The MRQ is 0.719. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.752. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.719TTM0.752-0.033
TTM0.752YOY0.848-0.096
TTM0.7525Y0.761-0.009
5Y0.76110Y0.718+0.043

2. Market Valuation of Chong Kun Dang Pharmaceutical

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₩1 in earnings Chong Kun Dang Pharmaceutical generates.

  • Above 15 is considered overpriced but always compare Chong Kun Dang Pharmaceutical to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 4.72 means the investor is paying ₩4.72 for every ₩1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Chong Kun Dang Pharmaceutical:

  • The EOD is 3.576. Based on the earnings, the company is cheap. +2
  • The MRQ is 4.719. Based on the earnings, the company is cheap. +2
  • The TTM is 6.069. Based on the earnings, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD3.576MRQ4.719-1.143
MRQ4.719TTM6.069-1.350
TTM6.069YOY15.206-9.138
TTM6.0695Y36.722-30.653
5Y36.72210Y39.426-2.705
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Chong Kun Dang Pharmaceutical:

  • The EOD is 2.573. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 3.395. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 6.908. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD2.573MRQ3.395-0.822
MRQ3.395TTM6.908-3.513
TTM6.908YOY-12.267+19.175
TTM6.9085Y-12.343+19.251
5Y-12.34310Y-4.632-7.712
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Chong Kun Dang Pharmaceutical is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of 2.04 means the investor is paying ₩2.04 for each ₩1 in book value.

Let's take a look of the Price to Book Ratio trends of Chong Kun Dang Pharmaceutical:

  • The EOD is 1.548. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.042. Based on the equity, the company is underpriced. +1
  • The TTM is 1.686. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.548MRQ2.042-0.495
MRQ2.042TTM1.686+0.356
TTM1.686YOY1.860-0.174
TTM1.6865Y2.514-0.827
5Y2.51410Y2.568-0.054
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Chong Kun Dang Pharmaceutical compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--6639.7493818.170+74%1089.955+509%1511.719+339%2563.863+159%
Book Value Per Share--64096.56356395.678+14%46788.556+37%44787.670+43%40999.040+56%
Current Ratio--1.8511.868-1%1.929-4%1.872-1%1.772+4%
Debt To Asset Ratio--0.4180.429-2%0.459-9%0.431-3%0.410+2%
Debt To Equity Ratio--0.7190.752-4%0.848-15%0.761-5%0.718+0%
Dividend Per Share----0%441.600-100%488.878-100%526.482-100%
Eps--6935.4194172.071+66%1590.427+336%1892.120+267%1682.915+312%
Free Cash Flow Per Share--9639.1784896.740+97%288.206+3245%1355.235+611%1223.215+688%
Free Cash Flow To Equity Per Share--9639.1784896.740+97%-32.810+100%1627.452+492%1398.225+589%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--522091.323--------
Intrinsic Value_10Y_min--435451.264--------
Intrinsic Value_1Y_max--12630.767--------
Intrinsic Value_1Y_min--12383.148--------
Intrinsic Value_3Y_max--68196.027--------
Intrinsic Value_3Y_min--64494.963--------
Intrinsic Value_5Y_max--160226.120--------
Intrinsic Value_5Y_min--146114.548--------
Market Cap1262329920000.000-32%1665715590000.0001223923786090.682+36%1102627975376.633+51%1398757381105.889+19%1403283784419.696+19%
Net Profit Margin--0.1750.124+42%0.055+220%0.066+164%0.062+182%
Operating Margin----0%0.074-100%0.067-100%0.070-100%
Operating Ratio--1.3121.467-11%1.422-8%1.493-12%1.498-12%
Pb Ratio1.548-32%2.0421.686+21%1.860+10%2.514-19%2.568-20%
Pe Ratio3.576-32%4.7196.069-22%15.206-69%36.722-87%39.426-88%
Price Per Share99200.000-32%130900.00096099.937+36%86649.848+51%109904.746+19%110263.730+19%
Price To Free Cash Flow Ratio2.573-32%3.3956.908-51%-12.267+461%-12.343+464%-4.632+236%
Price To Total Gains Ratio14.940-32%19.71530.567-36%73.180-73%80.367-75%78.313-75%
Quick Ratio--0.8110.691+17%0.829-2%0.759+7%0.758+7%
Return On Assets--0.0630.041+52%0.018+242%0.023+176%0.021+205%
Return On Equity--0.1080.072+50%0.034+218%0.040+172%0.037+191%
Total Gains Per Share--6639.7493818.170+74%1531.555+334%2000.598+232%3090.345+115%
Usd Book Value--570944618.125502823801.076+14%416772342.215+37%399044377.291+43%365277879.157+56%
Usd Book Value Change Per Share--4.6482.673+74%0.763+509%1.058+339%1.795+159%
Usd Book Value Per Share--44.86839.477+14%32.752+37%31.351+43%28.699+56%
Usd Dividend Per Share----0%0.309-100%0.342-100%0.369-100%
Usd Eps--4.8552.920+66%1.113+336%1.324+267%1.178+312%
Usd Free Cash Flow--85861649.97243636925.159+97%2567212.767+3245%12075623.552+611%10898888.216+688%
Usd Free Cash Flow Per Share--6.7473.428+97%0.202+3245%0.949+611%0.856+688%
Usd Free Cash Flow To Equity Per Share--6.7473.428+97%-0.023+100%1.139+492%0.979+589%
Usd Market Cap883630944.000-32%1166000913.000856746650.263+36%771839582.764+51%979130166.774+19%982298649.094+19%
Usd Price Per Share69.440-32%91.63067.270+36%60.655+51%76.933+19%77.185+19%
Usd Profit--61777732.94737191205.002+66%14166838.373+336%16859826.165+266%14995194.470+312%
Usd Revenue--353227733.243292145776.781+21%260460327.542+36%240927810.066+47%225387947.861+57%
Usd Total Gains Per Share--4.6482.673+74%1.072+334%1.400+232%2.163+115%
 EOD+4 -4MRQTTM+28 -4YOY+26 -95Y+28 -710Y+27 -8

3.2. Fundamental Score

Let's check the fundamental score of Chong Kun Dang Pharmaceutical based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-153.576
Price to Book Ratio (EOD)Between0-11.548
Net Profit Margin (MRQ)Greater than00.175
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.811
Current Ratio (MRQ)Greater than11.851
Debt to Asset Ratio (MRQ)Less than10.418
Debt to Equity Ratio (MRQ)Less than10.719
Return on Equity (MRQ)Greater than0.150.108
Return on Assets (MRQ)Greater than0.050.063
Total6/10 (60.0%)

3.3. Technical Score

Let's check the technical score of Chong Kun Dang Pharmaceutical based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5035.809
Ma 20Greater thanMa 50106,020.000
Ma 50Greater thanMa 100108,422.000
Ma 100Greater thanMa 200113,504.831
OpenGreater thanClose100,200.000
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in KRW. All numbers in thousands.

Summary
Total Assets1,402,428,436
Total Liabilities586,793,267
Total Stockholder Equity815,694,495
 As reported
Total Liabilities 586,793,267
Total Stockholder Equity+ 815,694,495
Total Assets = 1,402,428,436

Assets

Total Assets1,402,428,436
Total Current Assets946,571,861
Long-term Assets455,856,575
Total Current Assets
Cash And Cash Equivalents 219,646,348
Short-term Investments 145,418,947
Net Receivables 269,632,200
Inventory 261,431,892
Other Current Assets 0
Total Current Assets  (as reported)946,571,861
Total Current Assets  (calculated)896,129,388
+/- 50,442,473
Long-term Assets
Property Plant Equipment 319,787,118
Intangible Assets 52,527,146
Long-term Assets Other 171,504
Long-term Assets  (as reported)455,856,575
Long-term Assets  (calculated)372,485,768
+/- 83,370,807

Liabilities & Shareholders' Equity

Total Current Liabilities511,465,847
Long-term Liabilities75,327,420
Total Stockholder Equity815,694,495
Total Current Liabilities
Short Long Term Debt 181,698,926
Accounts payable 183,938,771
Other Current Liabilities 21,447,702
Total Current Liabilities  (as reported)511,465,847
Total Current Liabilities  (calculated)387,085,399
+/- 124,380,448
Long-term Liabilities
Long term Debt 30,000,000
Capital Lease Obligations Min Short Term Debt8,064,954
Long-term Liabilities Other 29,133,817
Long-term Liabilities  (as reported)75,327,420
Long-term Liabilities  (calculated)67,198,771
+/- 8,128,649
Total Stockholder Equity
Retained Earnings 577,002,400
Total Stockholder Equity (as reported)815,694,495
Total Stockholder Equity (calculated)577,002,400
+/- 238,692,095
Other
Capital Stock31,421,160
Common Stock Shares Outstanding 12,725
Net Invested Capital 1,027,393,421
Net Working Capital 435,106,014
Property Plant and Equipment Gross 642,786,135



Balance Sheet

Currency in KRW. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-03-31
> Total Assets 
0
676,953,297
686,737,712
684,579,766
711,494,874
722,387,150
748,223,783
770,908,834
801,352,143
829,957,478
887,607,360
964,267,905
946,333,120
941,499,511
946,884,783
1,080,040,167
1,046,700,072
1,068,486,799
1,097,288,193
1,110,286,810
1,124,882,798
1,168,868,086
1,185,242,226
1,270,390,620
1,402,428,436
1,402,428,4361,270,390,6201,185,242,2261,168,868,0861,124,882,7981,110,286,8101,097,288,1931,068,486,7991,046,700,0721,080,040,167946,884,783941,499,511946,333,120964,267,905887,607,360829,957,478801,352,143770,908,834748,223,783722,387,150711,494,874684,579,766686,737,712676,953,2970
   > Total Current Assets 
0
364,503,905
373,169,454
370,850,269
390,331,112
401,792,124
425,996,679
447,486,288
471,135,032
507,178,659
558,324,206
631,176,978
600,114,083
580,015,564
581,716,001
708,377,503
667,147,151
683,877,206
707,029,578
708,574,133
713,614,783
744,933,227
742,507,777
820,572,732
946,571,861
946,571,861820,572,732742,507,777744,933,227713,614,783708,574,133707,029,578683,877,206667,147,151708,377,503581,716,001580,015,564600,114,083631,176,978558,324,206507,178,659471,135,032447,486,288425,996,679401,792,124390,331,112370,850,269373,169,454364,503,9050
       Cash And Cash Equivalents 
0
44,851,445
17,165,919
25,754,594
45,948,687
60,061,885
58,545,021
81,817,778
76,922,516
85,783,309
152,326,728
141,952,857
123,659,075
125,414,235
122,521,135
223,349,042
131,812,684
105,305,676
115,037,205
106,400,044
117,416,899
150,881,777
146,154,531
226,049,672
219,646,348
219,646,348226,049,672146,154,531150,881,777117,416,899106,400,044115,037,205105,305,676131,812,684223,349,042122,521,135125,414,235123,659,075141,952,857152,326,72885,783,30976,922,51681,817,77858,545,02160,061,88545,948,68725,754,59417,165,91944,851,4450
       Short-term Investments 
0
0
0
0
0
0
0
0
15,450,732
18,967,382
6,740,322
38,641,314
38,196,327
19,613,581
16,451,058
7,715,419
55,519,916
64,206,136
51,603,874
44,678,629
38,444,295
31,864,435
39,853,307
17,437,889
145,418,947
145,418,94717,437,88939,853,30731,864,43538,444,29544,678,62951,603,87464,206,13655,519,9167,715,41916,451,05819,613,58138,196,32738,641,3146,740,32218,967,38215,450,73200000000
       Net Receivables 
0
197,657,169
211,761,222
207,059,272
208,288,489
172,838,502
183,033,016
172,973,966
198,006,776
199,727,070
199,292,402
232,477,942
219,513,879
220,184,988
215,732,975
224,917,981
228,294,942
237,213,655
237,095,001
255,950,379
279,748,603
220,049,769
234,046,999
253,011,588
269,632,200
269,632,200253,011,588234,046,999220,049,769279,748,603255,950,379237,095,001237,213,655228,294,942224,917,981215,732,975220,184,988219,513,879232,477,942199,292,402199,727,070198,006,776172,973,966183,033,016172,838,502208,288,489207,059,272211,761,222197,657,1690
       Other Current Assets 
0
7,984,431
5,772,848
6,322,008
5,521,030
5,583,815
5,556,899
0
29,966,592
31,036,346
33,891,520
34,912,367
31,240,621
24,975,484
24,387,080
26,893,126
24,669,755
28,098,168
28,675,459
28,855,138
5,911,899
335,286
346,588
266,847
0
0266,847346,588335,2865,911,89928,855,13828,675,45928,098,16824,669,75526,893,12624,387,08024,975,48431,240,62134,912,36733,891,52031,036,34629,966,59205,556,8995,583,8155,521,0306,322,0085,772,8487,984,4310
   > Long-term Assets 
0
0
0
0
0
320,595,026
322,227,103
323,422,546
330,217,112
322,778,819
329,283,154
333,090,927
346,219,038
361,483,947
365,168,782
371,662,664
379,552,921
384,609,593
390,258,615
401,712,677
411,268,015
423,934,859
442,734,449
449,817,888
455,856,575
455,856,575449,817,888442,734,449423,934,859411,268,015401,712,677390,258,615384,609,593379,552,921371,662,664365,168,782361,483,947346,219,038333,090,927329,283,154322,778,819330,217,112323,422,546322,227,103320,595,02600000
       Property Plant Equipment 
0
254,020,404
253,437,333
252,091,504
254,109,263
250,330,722
250,758,953
254,832,883
263,086,306
260,481,399
265,551,334
267,389,483
274,650,349
284,161,480
292,178,157
294,932,312
298,909,706
299,636,389
301,517,981
308,831,621
310,697,430
312,728,086
313,506,494
317,831,289
319,787,118
319,787,118317,831,289313,506,494312,728,086310,697,430308,831,621301,517,981299,636,389298,909,706294,932,312292,178,157284,161,480274,650,349267,389,483265,551,334260,481,399263,086,306254,832,883250,758,953250,330,722254,109,263252,091,504253,437,333254,020,4040
       Long Term Investments 
0
19,328,254
20,924,907
22,329,593
24,831,694
24,813,390
25,340,079
24,599,855
25,092,336
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000025,092,33624,599,85525,340,07924,813,39024,831,69422,329,59320,924,90719,328,2540
       Intangible Assets 
0
14,057,706
14,578,381
14,868,326
15,375,896
15,222,770
15,388,149
15,628,236
15,915,010
16,753,230
18,225,370
18,248,732
19,032,510
19,354,313
19,184,628
19,343,051
20,805,505
21,420,607
21,574,285
21,308,286
26,953,014
29,233,291
45,759,182
48,524,024
52,527,146
52,527,14648,524,02445,759,18229,233,29126,953,01421,308,28621,574,28521,420,60720,805,50519,343,05119,184,62819,354,31319,032,51018,248,73218,225,37016,753,23015,915,01015,628,23615,388,14915,222,77015,375,89614,868,32614,578,38114,057,7060
       Other Assets 
0
58,428,988
24,627,637
24,440,074
26,846,908
30,228,144
30,739,922
28,361,572
26,123,460
25,450,708
25,138,438
26,624,033
25,971,977
29,517,350
26,316,205
25,897,184
26,464,541
24,941,543
33,344,940
26,942,245
29,607,819
0
0
0
0
000029,607,81926,942,24533,344,94024,941,54326,464,54125,897,18426,316,20529,517,35025,971,97726,624,03325,138,43825,450,70826,123,46028,361,57230,739,92230,228,14426,846,90824,440,07424,627,63758,428,9880
> Total Liabilities 
0
288,310,970
281,342,369
265,146,388
280,595,304
289,713,173
303,673,774
312,319,452
326,398,912
348,379,428
378,456,354
419,475,552
394,740,342
392,457,343
380,130,607
513,094,122
480,890,429
502,931,680
513,876,059
498,986,624
503,593,996
527,863,460
499,746,861
539,246,916
586,793,267
586,793,267539,246,916499,746,861527,863,460503,593,996498,986,624513,876,059502,931,680480,890,429513,094,122380,130,607392,457,343394,740,342419,475,552378,456,354348,379,428326,398,912312,319,452303,673,774289,713,173280,595,304265,146,388281,342,369288,310,9700
   > Total Current Liabilities 
0
238,011,994
226,633,567
209,952,216
204,509,191
200,962,074
238,868,490
246,109,440
277,069,013
303,428,479
307,039,185
347,778,562
320,620,873
330,282,940
313,266,070
341,405,360
320,229,872
342,892,281
377,924,280
364,814,063
374,213,062
404,137,105
353,540,993
488,824,706
511,465,847
511,465,847488,824,706353,540,993404,137,105374,213,062364,814,063377,924,280342,892,281320,229,872341,405,360313,266,070330,282,940320,620,873347,778,562307,039,185303,428,479277,069,013246,109,440238,868,490200,962,074204,509,191209,952,216226,633,567238,011,9940
       Short-term Debt 
124,567,000
40,000,001
20,021,490
20,131,344
477,986
48,660,112
74,889,585
77,460,228
89,547,332
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000089,547,33277,460,22874,889,58548,660,112477,98620,131,34420,021,49040,000,001124,567,000
       Short Long Term Debt 
124,567,000
40,000,001
20,021,490
20,131,344
477,986
48,660,112
74,889,585
77,460,228
89,547,332
90,868,953
112,172,632
110,791,059
75,993,410
86,313,440
86,989,853
88,517,833
99,336,832
97,220,750
122,765,842
124,893,610
123,534,135
134,599,526
104,543,058
183,142,446
181,698,926
181,698,926183,142,446104,543,058134,599,526123,534,135124,893,610122,765,84297,220,75099,336,83288,517,83386,989,85386,313,44075,993,410110,791,059112,172,63290,868,95389,547,33277,460,22874,889,58548,660,112477,98620,131,34420,021,49040,000,001124,567,000
       Accounts payable 
0
68,339,005
85,001,681
62,918,439
68,591,984
69,959,433
89,709,292
88,691,093
101,969,485
122,063,148
108,486,261
138,228,191
144,120,057
121,675,638
130,612,652
135,299,223
129,327,403
150,339,455
163,028,776
138,087,076
145,436,254
154,493,252
142,361,547
196,433,657
183,938,771
183,938,771196,433,657142,361,547154,493,252145,436,254138,087,076163,028,776150,339,455129,327,403135,299,223130,612,652121,675,638144,120,057138,228,191108,486,261122,063,148101,969,48588,691,09389,709,29269,959,43368,591,98462,918,43985,001,68168,339,0050
       Other Current Liabilities 
0
88,433,488
50,570,709
55,509,900
62,754,911
7,872,299
8,433,887
18,290,218
70,062,595
83,868,293
77,872,043
88,837,335
88,699,649
116,390,708
86,815,352
97,095,899
78,567,747
88,971,833
81,242,801
90,651,583
93,270,975
22,253,850
22,163,655
22,835,385
21,447,702
21,447,70222,835,38522,163,65522,253,85093,270,97590,651,58381,242,80188,971,83378,567,74797,095,89986,815,352116,390,70888,699,64988,837,33577,872,04383,868,29370,062,59518,290,2188,433,8877,872,29962,754,91155,509,90050,570,70988,433,4880
   > Long-term Liabilities 
0
0
0
0
0
88,751,099
64,805,284
66,210,012
49,329,900
44,950,949
71,417,170
71,696,990
74,119,469
62,174,403
66,864,537
171,688,762
160,660,556
160,039,399
135,951,779
134,172,561
129,380,934
123,726,355
146,205,869
50,422,210
75,327,420
75,327,42050,422,210146,205,869123,726,355129,380,934134,172,561135,951,779160,039,399160,660,556171,688,76266,864,53762,174,40374,119,46971,696,99071,417,17044,950,94949,329,90066,210,01264,805,28488,751,09900000
       Other Liabilities 
0
24,491,995
28,183,037
29,309,788
30,194,019
30,581,019
31,479,766
33,334,433
23,484,614
21,261,016
22,460,874
22,714,447
16,610,230
13,694,792
19,767,144
25,339,307
25,698,227
22,492,433
22,255,356
19,938,585
18,088,356
0
0
0
0
000018,088,35619,938,58522,255,35622,492,43325,698,22725,339,30719,767,14413,694,79216,610,23022,714,44722,460,87421,261,01623,484,61433,334,43331,479,76630,581,01930,194,01929,309,78828,183,03724,491,9950
> Total Stockholder Equity
354,250,381
387,216,609
402,775,919
417,097,986
428,725,142
430,790,102
442,851,200
457,049,356
473,520,116
480,789,334
508,007,160
544,051,136
551,426,758
549,187,226
567,560,488
568,231,251
566,009,985
565,686,557
584,171,139
612,489,798
622,393,068
641,938,538
686,096,523
731,084,223
815,694,495
815,694,495731,084,223686,096,523641,938,538622,393,068612,489,798584,171,139565,686,557566,009,985568,231,251567,560,488549,187,226551,426,758544,051,136508,007,160480,789,334473,520,116457,049,356442,851,200430,790,102428,725,142417,097,986402,775,919387,216,609354,250,381
   Common Stock
0
24,698,090
24,698,090
24,698,090
24,698,090
25,925,725
25,925,725
25,925,725
25,925,725
27,214,213
27,214,213
27,214,213
27,214,213
28,565,248
28,565,248
28,565,248
28,565,248
29,970,095
29,970,095
29,970,095
29,970,095
0
0
0
0
000029,970,09529,970,09529,970,09529,970,09528,565,24828,565,24828,565,24828,565,24827,214,21327,214,21327,214,21327,214,21325,925,72525,925,72525,925,72525,925,72524,698,09024,698,09024,698,09024,698,0900
   Retained Earnings Total Equity0000000000000000000000000
   Accumulated Other Comprehensive Income 0000000000000000000000000
   Capital Surplus 0000000000000000000000000
   Treasury Stock000000000000000000000-7,333,825-7,333,825-7,333,8250
   Other Stockholders Equity 0000-6,966,574-7,984,425-7,498,235-6,541,598-6,843,142-6,696,470-5,638,341-4,407,185-5,151,776-4,374,132-4,285,979-4,074,916-2,637,499-1,565,376-1,220,576-1,145,713-1,397,201-204,083-657,533-1,411,1760



Balance Sheet

Currency in KRW. All numbers in thousands.




Cash Flow

Currency in KRW. All numbers in thousands.




Income Statement

Currency in KRW. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue1,669,404,439
Cost of Revenue-1,007,202,930
Gross Profit662,201,509662,201,509
 
Operating Income (+$)
Gross Profit662,201,509
Operating Expense-1,422,805,160
Operating Income246,599,279-760,603,651
 
Operating Expense (+$)
Research Development140,234,542
Selling General Administrative131,375,828
Selling And Marketing Expenses0
Operating Expense1,422,805,160271,610,370
 
Net Interest Income (+$)
Interest Income5,789,283
Interest Expense-9,270,969
Other Finance Cost-1
Net Interest Income-3,481,687
 
Pretax Income (+$)
Operating Income246,599,279
Net Interest Income-3,481,687
Other Non-Operating Income Expenses0
Income Before Tax (EBT)241,597,848246,599,279
EBIT - interestExpense = -9,270,969
212,521,171
221,792,140
Interest Expense9,270,969
Earnings Before Interest and Taxes (EBIT)0250,868,817
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax241,597,848
Tax Provision-27,995,661
Net Income From Continuing Ops213,602,187213,602,187
Net Income212,521,171
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net03,481,687
 

Technical Analysis of Chong Kun Dang Pharmaceutical
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Chong Kun Dang Pharmaceutical. The general trend of Chong Kun Dang Pharmaceutical is BEARISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Chong Kun Dang Pharmaceutical's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-42.9%) Bearish trend (42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Chong Kun Dang Pharmaceutical.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 115,500 < 116,800 < 119,100.

The bearish price targets are: 97,048 > 86,571 > 85,619.

Tweet this
Chong Kun Dang Pharmaceutical Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Chong Kun Dang Pharmaceutical. The current mas is .

The long score for the Moving Averages is 4/14.
The longshort score for the Moving Averages is -6/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Chong Kun Dang Pharmaceutical Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Chong Kun Dang Pharmaceutical. The current macd is -2,784.75315233.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Chong Kun Dang Pharmaceutical price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Chong Kun Dang Pharmaceutical. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Chong Kun Dang Pharmaceutical price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Chong Kun Dang Pharmaceutical Daily Moving Average Convergence/Divergence (MACD) ChartChong Kun Dang Pharmaceutical Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Chong Kun Dang Pharmaceutical. The current adx is 25.26.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Chong Kun Dang Pharmaceutical shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Chong Kun Dang Pharmaceutical Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Chong Kun Dang Pharmaceutical. The current sar is 103,957.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Chong Kun Dang Pharmaceutical Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Chong Kun Dang Pharmaceutical. The current rsi is 35.81. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Chong Kun Dang Pharmaceutical Daily Relative Strength Index (RSI) ChartChong Kun Dang Pharmaceutical Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Chong Kun Dang Pharmaceutical. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Chong Kun Dang Pharmaceutical price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Chong Kun Dang Pharmaceutical Daily Stochastic Oscillator ChartChong Kun Dang Pharmaceutical Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Chong Kun Dang Pharmaceutical. The current cci is -88.10765388.

Chong Kun Dang Pharmaceutical Daily Commodity Channel Index (CCI) ChartChong Kun Dang Pharmaceutical Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Chong Kun Dang Pharmaceutical. The current cmo is -32.98887203.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Chong Kun Dang Pharmaceutical Daily Chande Momentum Oscillator (CMO) ChartChong Kun Dang Pharmaceutical Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Chong Kun Dang Pharmaceutical. The current willr is -94.44444444.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Chong Kun Dang Pharmaceutical Daily Williams %R ChartChong Kun Dang Pharmaceutical Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Chong Kun Dang Pharmaceutical.

Chong Kun Dang Pharmaceutical Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Chong Kun Dang Pharmaceutical. The current atr is 3,166.

Chong Kun Dang Pharmaceutical Daily Average True Range (ATR) ChartChong Kun Dang Pharmaceutical Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Chong Kun Dang Pharmaceutical. The current obv is 5,307,091.

Chong Kun Dang Pharmaceutical Daily On-Balance Volume (OBV) ChartChong Kun Dang Pharmaceutical Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Chong Kun Dang Pharmaceutical. The current mfi is 23.27.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Chong Kun Dang Pharmaceutical Daily Money Flow Index (MFI) ChartChong Kun Dang Pharmaceutical Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Chong Kun Dang Pharmaceutical.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-24STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-11-30STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-05SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-07CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-11STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-13STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-14BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-15STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-19CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-20WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-26ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-28RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-01-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-31DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-02-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-13STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-15STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-27STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-19CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-27STOCH LONG EXITThe %K line crosses below the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-29CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-01CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-04BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside

6.3. Candlestick Patterns

Chong Kun Dang Pharmaceutical Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Chong Kun Dang Pharmaceutical based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5035.809
Ma 20Greater thanMa 50106,020.000
Ma 50Greater thanMa 100108,422.000
Ma 100Greater thanMa 200113,504.831
OpenGreater thanClose100,200.000
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Chong Kun Dang Pharmaceutical with someone you think should read this too:
  • Are you bullish or bearish on Chong Kun Dang Pharmaceutical? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Chong Kun Dang Pharmaceutical? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Chong Kun Dang Pharmaceutical

I send you an email if I find something interesting about Chong Kun Dang Pharmaceutical.


Comments

How you think about this?

Leave a comment

Stay informed about Chong Kun Dang Pharmaceutical.

Receive notifications about Chong Kun Dang Pharmaceutical in your mailbox!